|
|
|
42
|
68719
|
IBUFEN 20MG/ML SUSP (CAR) IBUPROFEN
|
IBUPROFEN
|
IBUFEN
|
125ML
|
A
|
5.98
|
0.05
|
ML
|
100
|
BOTT
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
6871AA
|
IBUPROFEN 20MG/ML SUSP (KWA)
|
IBUPROFEN
|
IBUPROFEN
|
125ML
|
A
|
5.41
|
0.0433
|
ML
|
100
|
BOTT
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6871U
|
ADVIL FRUIT 20MG/ML SUSP (GSK/COL) IBUPROFEN
|
IBUPROFEN
|
ADVIL FRUIT
|
120ML
|
C
|
10.79
|
0.09
|
SUSPENSION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6871U
|
ADVIL FRUIT 20MG/ML SUSP (GSK) IBUPROFEN (C)
|
IBUPROFEN
|
ADVIL FRUIT
|
120ML
|
C
|
11.34
|
0.0945
|
ML
|
100
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6871V
|
ADVIL GRAPE 20MG/ML SUSP (GSK/COL) IBUPROFEN
|
IBUPROFEN
|
ADVIL GRAPE
|
120ML
|
C
|
10.79
|
0.09
|
SUSPENSION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6871V
|
ADVIL GRAPE 20MG/ML SUSP (GSK) IBUPROFEN (C)
|
IBUPROFEN
|
ADVIL GRAPE
|
120ML
|
C
|
11.34
|
0.0945
|
ML
|
100
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6871Y
|
IBUPROFEN 20MG/ML SUSP (CHC/ATB)
|
IBUPROFEN
|
IBUPROFEN
|
125ML
|
A
|
1.85
|
0.01
|
SUSPENSION
|
100
|
ML
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
6871Z
|
IBUPROFEN 20MG/ML SUSP (LDP)
|
IBUPROFEN
|
IBUPROFEN
|
100ML
|
A
|
3.45
|
0.0345
|
ML
|
100
|
BOTT
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
68911
|
E-Z-GAS II (EZM/COL) SOD BIC/CIT ACID/SIMET
|
CITRIC ACID|SIMETHICONE|SODIUM BICARBONATE
|
E-Z-GAS II
|
50X4G
|
BQ
|
462.12
|
9.24
|
|
0
|
SACH
|
EZM
|
E-Z-EM INC.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
DIAGNOSTIC AGENTS
|
|
|
|
|
41
|
68911
|
E-Z-GAS II (EZM) SOD BIC/CIT ACID/SIME (BQ)
|
CITRIC ACID|SIMETHICONE|SODIUM BICARBONATE
|
E-Z-GAS II
|
50X4G
|
BQ
|
508.33
|
10.1665
|
SACH
|
0
|
BOX
|
EZM
|
E-Z-EM INC.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
42
|
68911
|
E-Z-GAS II (EZM) SOD BIC/CIT ACID/SIME
|
CITRIC ACID|SIMETHICONE|SODIUM BICARBONATE
|
E-Z-GAS II
|
50X4G
|
BQ
|
532.79
|
10.66
|
SACH
|
0
|
BOX
|
EZM
|
E-Z-EM INC.
|
COL
|
AVENTA BARBADOS
|
|
3668
|
ROENTGENOGRAPHY
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
40
|
7091M
|
CARBOPLATIN 150MG INJ (INP/AHI)
|
CARBOPLATIN
|
CARBOPLATIN
|
150MG VIAL
|
BQ
|
36.91
|
36.91
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
7091N
|
CARBOPLATIN 150MG INJ (FSB) (BQ)
|
CARBOPLATIN
|
CARBOPLATIN
|
150MG VIAL
|
BQ
|
36.97
|
36.9692
|
VIAL
|
10
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
7091V
|
CARBOPLATIN 150MG INJ (FSB)
|
CARBOPLATIN
|
CARBOPLATIN
|
150MG VIAL
|
BQ
|
33.44
|
33.44
|
VIAL
|
10
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
2026-03-05
|
|
|
|
41
|
7093F
|
CARBOPLATIN 450MG INJ (DIL) (BQ)
|
CARBOPLATIN
|
CARBOPLATIN
|
450MG VIAL
|
BQ
|
91.58
|
91.5803
|
VIAL
|
10
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7093L
|
CARBOPLATIN 450MG INJ (FSB/ATB)
|
CARBOPLATIN
|
CARBOPLATIN
|
450MG VIAL
|
BQ
|
76.11
|
76.11
|
INJECTION
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
7093L
|
CARBOPLATIN 450MG INJ (FSB) (BQ)
|
CARBOPLATIN
|
CARBOPLATIN
|
450MG VIAL
|
BQ
|
76.17
|
76.1674
|
VIAL
|
10
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7093N
|
CARBOPLATIN 450MG INJ (INP/AHI)
|
CARBOPLATIN
|
CARBOPLATIN
|
450MG VIAL
|
BQ
|
84.62
|
84.62
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
7093Q
|
CARBOTHER 450MG INJ (TPP) CARBOPLAT
|
CARBOPLATIN
|
CARBOTHER
|
450MG VIAL
|
BQ
|
76.11
|
76.11
|
VIAL
|
10
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
7093S
|
BIOCARB 450MG INJ (ZYD) CARBOPLATIN
|
CARBOPLATIN
|
BIOCARB
|
450MG VIAL
|
BQ
|
97.53
|
97.53
|
VIAL
|
10
|
VIAL
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV/IM/SC
|
0
|
ANTINEOPLASTICS
|
|
